A Multimeric Synthetic Peptide Combinatorial Library. 1994

A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
Istituto di Richerche di Biologia Molecolare P. Angeletti, Pomezia, Roma, Italy.

We describe here a novel type of synthetic peptide library, named Multimeric Synthetic Peptide Combinatorial Library (M-SPCL), where multiple small peptide ligands are tied together in the same molecule. The advantage of using small peptides in the form of M-SPCL is two-fold: first, the high density assembly of the sequences on the branching scaffold leads to signal amplification, thereby effectively lowering the binding threshold for the selection of ligands; second, to interfere with protein-protein interactions, multimericity has been shown to be a desirable feature per se. The M-SPCL is prepared by solid-phase peptide synthesis, based on the structure of Multiple Antigen Peptides. When prepared in Positional Scanning format [C. Pinilla, J. Appel, P. Blanc and R.A. Houghten. 1992. BioTechniques 13: 901-905], selection is based on the amplified interaction of a single residue in a sequence-defined position. The usefulness of the new library was demonstrated by the selection of octameric peptides, which inhibit the binding of the cytokine human interleukin-6 to its receptor, with an apparent nanomolar affinity. Tetrameric, but not dimeric, branched peptides with the same sequences were also active with comparable affinity. The success of this approach is noteworthy, since screening of the corresponding monomeric pentapeptide SPCL did not lead to the selection of any inhibitory compound in the same system.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D018123 Receptors, Interleukin Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells. Interleukin Receptors,Interleukin Receptor,Receptors, Interleukins,Interleukins Receptors,Receptor, Interleukin
D019947 Receptors, Interleukin-6 Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130. IL-6 Receptors,Interleukin-6 Receptor,Interleukin-6 Receptors,Receptors, IL-6,IL-6 Receptor,IL6 Receptor,IL6 Receptors,Interleukin 6 Receptor,IL 6 Receptor,IL 6 Receptors,Interleukin 6 Receptors,Receptor, IL-6,Receptor, IL6,Receptor, Interleukin 6,Receptor, Interleukin-6,Receptors, IL 6,Receptors, IL6,Receptors, Interleukin 6

Related Publications

A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
March 1995, Journal of molecular biology,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
August 2017, Experimental dermatology,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
July 1994, Bio/technology (Nature Publishing Company),
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
January 1998, Methods in molecular biology (Clifton, N.J.),
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
May 2002, Applied and environmental microbiology,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
November 2012, Organic letters,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
January 2003, Experimental hematology,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
January 2021, Chemical biology & drug design,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
January 2000, Methods in enzymology,
A Wallace, and S Altamura, and C Toniatti, and A Vitelli, and E Bianchi, and P Delmastro, and G Ciliberto, and A Pessi
July 2001, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!